PacBio to Report Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023

Rhea-AI Summary

PacBio (NASDAQ: PACB) announced it will hold a conference call on February 16, 2023, at 4:30 PM ET to discuss its fourth quarter and full year 2022 financial results. The call will be accessible via webcast on the company's investor relations website. PacBio is known for developing advanced sequencing solutions aimed at resolving complex genetic problems, utilizing its HiFi long read and emerging SBB® short read sequencing technologies for various research applications, including oncology and infectious diseases.

Positive

• Upcoming conference call scheduled for February 16, indicating ongoing transparency.
• Company recognized for advanced sequencing technologies addressing multiple research applications.

Negative

• None.

MENLO PARK, Calif., Feb. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, at 4:30 pm Eastern Time.

The call will be webcast and may be accessed at PacBio's website at: https://investor.pacificbiosciences.com/.

Date: Thursday, February 16, 2023 at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 866-652-5200
International: 412-317-6060

If using the dial-in option, please dial into the call five to ten minutes prior to start time using the appropriate number above and ask to join the "PacBio Q4 Earnings Call."

About PacBio

Pacific Biosciences of California, Inc. is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems.  Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit www.pacb.com and follow @PacBio.

Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-16-2023-301737858.html

SOURCE Pacific Biosciences of California, Inc.

FAQ

When is PacBio's conference call to discuss Q4 2022 results?

PacBio's conference call is scheduled for February 16, 2023, at 4:30 PM ET.

How can I access PacBio’s Q4 2022 earnings call?

You can access the Q4 2022 earnings call via webcast on PacBio's investor relations website.

What is the focus of PacBio's technologies?

PacBio focuses on developing advanced sequencing solutions for complex genetic issues, including oncology and infectious diseases.

What is the ticker symbol for Pacific Biosciences?

The ticker symbol for Pacific Biosciences is PACB.